跳至主要内容
临床试验/NCT07080983
NCT07080983已完成不适用

Efficacy of Corneal Cross-Linking (CXL) in the Treatment of Pediatric Keratoconus

Al-Azhar University3 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
3
主要终点
keratometry (Kmax)

研究概览

简要总结

This prospective interventional study investigates the efficacy of corneal cross-linking (CXL) in managing progressive keratoconus in pediatric patients. The procedure involved standard epithelium-off CXL, and patients were followed to assess outcomes such as visual acuity, keratometric stability, and corneal thickness.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 8 and 18 years
  • Clinical and topographic diagnosis of keratoconus based on the Belin/Ambrosio Enhanced Ectasia Display
  • Evidence of progression within the past 6-12 months (e.g., an increase in maximum keratometry (Kmax) by ≥1.0 diopter, a decrease in minimal corneal thickness by ≥10 µm, or deterioration in visual acuity not attributable to other causes

排除标准

  • Corneal scarring or opacities.
  • Active ocular infection or inflammation.
  • Prior ocular surgery or trauma.
  • Autoimmune or connective tissue disorders.

结局指标

主要结局

keratometry (Kmax)

时间窗: After 12 months

Kmax (Maximum Keratometry) is the steepest point of curvature on the cornea, and it is a key parameter in diagnosing and monitoring keratoconus.

BCVA

时间窗: After 12 months

Measurment of the visual acuity

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ehab Tharwat

Princibal Investigator

Al-Azhar University

研究点 (3)

Loading locations...

相似试验